logo
Select company
Select metric
$ -2.53MShareholders Equity
VS
Market
11
Sector
13
Industry
13
History
41
$ 9.42Close
$ 8.77 - $ 25.14 52-Week Range
Ticker Information

Ticker

RNAC

Company Name

CARTESIAN THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

CARTESIAN THERAPEUTICS INC - Shareholders Equity Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

RNAC - Equity Historical data
DateShareholders Equity
6/30/2025$ -2.53M
3/31/2025$ -21.79M
12/31/2024$ -6.8M
9/30/2024$ 752K
6/30/2024$ -101.46M
3/31/2024$ -116.8M
12/31/2023$ -440.18M
9/30/2023$ 60.33M
6/30/2023$ 65.45M
3/31/2023$ 74.58M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • CARTESIAN THERAPEUTICS INC's latest trailing twelve months (TTM) Equity stands at $ -7.38M.
  • Over the past 5 years, CARTESIAN THERAPEUTICS INC's average Equity has been $ -10.49M.
  • The median Equity for CARTESIAN THERAPEUTICS INC during this period was $ -3.37M
  • CARTESIAN THERAPEUTICS INC reached its highest Equity over the past 5 years at $ 93.83M.
  • The lowest Equity recorded by CARTESIAN THERAPEUTICS INC in the same timeframe $ -440.18M

CARTESIAN THERAPEUTICS INC's Equity vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Equity Benchmarks
CompanyEquity
HUMA : HUMACYTE INC $ 4.05MNWBO : NORTHWEST BIOTHERAPEUTICS INC $ -100.39MMREO : MEREO BIOPHARMA GROUP PLC $ 54.18MINBX : INHIBRX BIOSCIENCES INC $ 68.56MCRDF : CARDIFF ONCOLOGY INC $ 58.61MBTAI : BIOXCEL THERAPEUTICS INC $ -107.67MCATX : PERSPECTIVE THERAPEUTICS INC $ 265.69MADVM : ADVERUM BIOTECHNOLOGIES INC $ -20.22MSONN : SONNET BIOTHERAPEUTICS HOLDINGS INC $ -3.05MLSTA : LISATA THERAPEUTICS INC $ 21.03M

Definition of Shareholders Equity

[Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.

RNAC - Shareholders Equity, Last 5 years

$ -440.18M

Minimum

Dec 31, 2023

$ 93.83M

Maximum

Dec 31, 2022

$ -10.49M

Average

$ -3.37M

Median

Equity Benchmark Analysis

The chart above depicts the distribution of Equity for companies in the Total Stock Market. The average Equity of the companies is $ 384.65M with a standard deviation of $ 549.08M.
The following table provides additional summary stats:
Equity in the Market:
filtered constituents3.47K
min$ -1.4B
max$ 2.14B
average$ 384.65M
median$ 166.2M
std$ 549.08M